EPIDEMIC OF THYROID NODULES. HOW ARE THEY BEING FOUND?
|
|
- Tobias Wheeler
- 7 years ago
- Views:
Transcription
1 EPIDEMIC OF THYROID NODULES. HOW ARE THEY BEING FOUND? Jessica K. Levine, BA Robert A. Levine, MD, FACE, ECNU Thyroid Center of New Hampshire Introduction Thyroid nodules are epidemic. Approximately 4% of the population has a thyroid nodule palpable on physical examination. Far more are detectable with ultrasound study. It is estimated that with high-resolution ultrasound approximately 50-60% of the population will have a discernible nodule. Over the past seven years the discovery of thyroid cancer has doubled with an approximately 57,000 cases diagnosed in the US in Paralleling this increase in cancer, the number of biopsies performed in the US has dramatically increased (doubled) to 450,000 per year. We sought to evaluate how thyroid nodules were detected, and whether a correlation exists between the method of detection and rate of malignancy. METHODS The medical records of 200 consecutive patients referred for evaluation of thyroid nodules were reviewed. All consultations were performed by a single physician (Robert A. Levine, MD, FACE, ECNU) at the Thyroid Center of New Hampshire. The mode of discovery of the nodule was determined from the medical record. Major categories included detection at a physical examination by the referring clinician, being found by the patient, and being incidental discovery at another diagnostic study such as CT, MRI, or carotid ultrasound. Additional information reviewed included age and sex of the patient, size and number of nodules, whether a biopsy was performed, and if biopsied, whether benign or malignant. RESULTS Mode of Discovery Of the 200 cases, 67 (33.5%) were found on other imaging studies, including 35 CT scans, 15 MRI studies, and 8 carotid US studies. 75 (37.5%) were found on physical examination. Twenty four (12%) were initially found by the patient. Thirty four (17%) cases were found when a thyroid ultrasound was ordered for other reasons, such as abnormal thyroid function tests. Within the 17% in which the nodule was found for other reasons, in half there was no clear indication for an ultrasound initially being performed. Biopsy was performed in 141 (70%) cases and not performed in 59 cases (30%). In 42 cases biopsy was not performed due to the nodule not meeting current guidelines for biopsy, based on size and lack of suspicious ultrasound features. In 4 cases biopsy was not performed due to age and co-morbidities. Two patients had a benign biopsy prior to consultation. Biopsy was not performed in 9 cases due to the presence of Hashimoto s thyroiditis without significant or suspicious nodules. In two additional cases no nodule was present. Incidence of Cancer Related to Mode of Discovery Twelve of the 141 biopsies (8.5%) were surgically confirmed as cancer. Of these 12 cases seven were initially detected during physical examination, and 3 were detected by the patient. Only one cancer was found in patients referred due to an abnormality detected by another imaging study. One cancer case was detected during ultrasound evaluation of hyperparathyroidism. Thus 9% of the nodules found at physical exam were malignant while only 1.5% of those found incidentally at other imaging were malignant. Within the cancer cases, eight (67%) were lymph node negative and four (33%) had positive lateral lymph nodes. Three cases were T2N1bM0(clin) and one case was T3N1bM1.
2 Discussion Thyroid nodules are extremely common with 4% of the population having a palpable nodule and over 50% having a nodule detectable on high-resolution ultrasound. There has been a dramatic increase in the number of thyroid nodules referred for evaluation over the past two decades. As demonstrated in this study, a significant number of the nodules detected are found incidentally at other imaging studies, including CT, MRI, and carotid ultrasound. Prior studies have demonstrated the incidence of incidental thyroid nodules found at CT to range between 16% and 25%. With approximately 375,000 Chest CT scans performed annually on Medicare patients in the United States, the number of incidental thyroid nodules found in Medicare patients from this modality alone could range between 60,000 and 93,000 cases. This study demonstrated a very low rate of cancer in those nodules detected incidentally at other imaging studies. This is in contrast to several earlier reports. Yoon et al. examined 734 chest CT scans and found thyroid nodules in 16% of the studies. They reported that 9% of these incidentally found nodules were malignant. Liebeskind et al. found a 17% incidence of malignancy in 35 patients with nodules detected on chest CT, but this study was limited by a small sample size and probable pre-selection bias. Shetty et al. reported a 3.9% malignancy rate and a 7.4% potentially malignant (indeterminate biopsy) rate in patients who underwent fine needle aspiration biopsy after a report of incidental thyroid abnormality on CT. In contrast, the current study showed only a 1.5% rate of cancer in those patients with nodules detected incidentally on other imaging studies. The small sample size of this study may account for this discrepancy. In contrast, we found a much higher rate of cancer in those nodules detected by physical examination or reported by the patient. Since hard nodules are more apparent on examination, and nodule stiffness has shown a good correlation with risk of malignancy, it makes sense that those nodules that are easily detected on examination would more likely be malignancy. There are no clear guidelines regarding whether all nodules detected on CT or MRI studies should be evaluated further for malignancy. Recommendations have included that all nodules be reported, and that the decision whether to further evaluate the nodule be left to referring physicians, as they have a better understanding of the patient s medical history and risk factors. NCI guidelines recommend that an US be performed when a thyroid nodule is found on a CT scan. Prior studies have demonstrated a poor correlation between CT and ultrasound characteristics, and ultrasound is considered better able to discriminate between benign and suspicious features of nodules. In an editorial in Radiology published in 2008, Dr. John Cronin discussed the economic impact of evaluating all nonpalpable thyroid nodules. With a conservative estimate that 50% of the US population has a thyroid nodule, there is a potential reservoir of 150 million Americans awaiting ultrasound interrogation in order to determine whether to perform a biopsy. If 10% of those assessed have thyroid cancer, he estimated that it would cost $30 billion for biopsy and surgery alone in these patients. This is clearly an excessive cost for a disease with a mortality rate of 1500 patients per year. With 450,000 biopsies being performed to detect the 57,000 cases of thyroid cancer a year, (with 40% of cancers measuring less than 1 cm), there is clearly a need to decrease the number of patients being evaluated with small, incidentally found, low suspicion nodules. The American Thyroid Association is revising the current guidelines regarding which nodules need biopsy and which nodules can be observed without biopsy. Guidelines for determining which nodules incidentally found on other imaging studies should be further evaluated are also needed.
3 Direction for Future Study We plan to repeat this study in a similar thyroid center in Sarasota, Florida and in a university-based medical center thyroid clinic. We will evaluate whether the low rate of cancer in incidentally found lesions is confirmed with a larger patient population, as well as explore the differences in the mode of discovery of the nodules in different geographic regions and in centers with different referral patterns. Conclusion Of 200 consecutive referrals for thyroid nodules, 37.5% were found on physical examination, and 33.5 % were found incidentally on other imaging studies. While prior studies have suggested that incidentally detected nodules have a similar rate of malignancy to those found clinically, this study found a much higher rate of cancer in cases found by physical examination (9%) compared to those detected incidentally on other imaging studies (1.5%). References Ahmed S, Johnson PT, Horton KM et al. Prevalence of unsuspected thyroid nodules in adults on contrast enhanced 16-and 64-MDC of the chest. World J Radiol 2012;4(7): Shetty SK, Maher MM, Hahn PF, et al. Significance of Incidental Thyroid Lesions Detected on CT: Correlation among CT, Sonography, and Pathology. Am J Roentgenol 2006;187(5): Yoon DY, Chang SK, Choi CS, et al. The prevalence and significance of incidental thyroid nodules identified on computed tomography. J Comput Assist Tomogr 2008; 32(5): Liebeskind A, Sikora AG, Komisa A, et al. rates for malignancy in incidentally discovered thyroid nodules evaluated with sonography and fine needle aspiration. Journal of Ultrasound in Medicine 2005;24(5) Li H, Robinson KA, Anton B et al. Cost-effectiveness of a novel molecular test for psychologically indeterminate thyroid nodules. J Clin Endocrinol Metab 2011;96 (11)E Cronin JJ. Thyroid nodules: Is it time to turn off the US machines. Radiology 2008; 247(3) Levine RA. Current guidelines for the management of thyroid nodules. Endocrine Practice 2012; 18 (4) Ahmed S, Horton KM, Brooke Jeffrey R, et al. Incidental thyroid nodules on chest CT: Review of the literature and management suggestions. AJR 2010;195:
4 1 Epidemic of thyroid Nodules How are they being found? Jessica K. Levine, BA Robert A. Levine, MD, FACE, ECNU Thyroid Center of New Hampshire Geisel School of Medicine, Dartmouth College (RAL) College of Special Studies, Tufts University (JKL) 2 Introduction Thyroid nodules are epidemic 4% of population has a palpable nodule 50-60% of population has nodule detectable on high resolution ultrasound 450,000 Thyroid biopsies performed yearly in US cases of thyroid cancer diagnosed per year (2012) The number of biopsies and the number of cancers diagnosed have doubled over past 7 years The number of deaths from thyroid cancer has remained stable at approximately 1500 per year over several decades. Questions How are nodules being detected? Does the mode of detection impact on the rate of cancer? 3 Study Design 4 Patient demographics 200 consecutive referrals for thyroid nodules Thyroid specialty private practice in New Hampshire Retrospective chart review Data Extracted from Medical record Age Sex Mode of Discovery Ultrasound Characteristics Single vs. Multiple nodules Whether biopsy was performed and why/not Outcome of biopsy and surgical correlation in malignant or suspicious samples Female : Male 167:33 (5:1) Mean age years (range 19-92) Single versus MNG 87 single (43.5%), 102 MNG (51%), (11 no nodule) Biopsy performed in 70% 5 Results 6 Method of nodule discovery for all patients in the study 67/200 found by other imaging 35 CT 16 MRI 8 carotid US 2 PET 75 found at physical exam by physician or NP 24 found by patient 34 Other reasons Abnormal labs Abnormal TFTs hyperparathyroid Neck symptoms 12 Misc 67/ % 34/200 17% 24/200 12% 75/ % Physical Exam Found by pt Other imaging Other
5 7 Breakdown of other category 8 8 Decision for/against biopsy Appropriate indication Dysphagia 6 History of nodule 2 Neck discomfort 5 Cervical adenopathy 1 Jaw Lump 1 Hyperparathyroidism 1 16/34 appropriate Questionable indication Abnormal TFTs / hypothyroidism 14 Sinusitis/URI 3 Fatigue 1 18/34 questionable than Biopsy performed in 141 patients(70%) Biopsy not performed in 59 patients (30%) 42 (71%) Did not meet guidelines for biopsy < 1 cm and no suspicious features (calcifications, infiltrative margins, taller wide, hypoechoic) 4 (7%) due to age and co-morbidities 9 (15%) Hashimoto s without discrete nodule 2 (3%) prior benign biopsy 2 (3%) no nodule found 8.5% male in the biopsy group v 20% in the 9 Cancer Cases 10 Malignancy rate by method of discovery 12 of 200 (6%) of cases were diagnosed with cancer 12 of 141 (8.5%)biopsies diagnosed with cancer 7 (58%) nodule found at physical examination 3 (33%)nodule found by patient 1 detected by other imaging study 1 detected by other (US for hyperparathyroidism) 7/75 (9%) of nodules found at PE were malignant 1/67 (1.5%) of nodules found incidentally at other imaging malignant PE pt other imaging other cancer total 7/75 = 9% 3/24 = 12.5% 1/67 = 1.5% 1/34 = 3% 11 Cancer Cases 12 Discussion cases T1-3 N0 M0 clin 3 cases T2N1bM0 1 case T2N1bM 33% of cancer cases had positive lymph nodes detected on pre-operative US Thyroid nodules are extremely common Palpable nodules in 4% and demonstrable by ultrasound in 50-60% Vast majority are benign with only 57,000 cases of cancer diagnosed per year and only 1500 deaths per year. Incidental thyroid nodules are found in 16 25% of all chest CT scans 375,000 chest CT scans performed on Medicare patients each year 60,000 90,000 nodules detected on chest CT of Medicare patients alone.
6 13 Discussion Discussion - 3 This study demonstrated a very low rate of malignancy (1.5%) in nodules detected incidentally at other imaging studies. Prior studies have shown a higher rate of malignancy in incidental nodules The malignancy rate will be impacted by the process by which nodules found incidentally at other imaging studies are reported and evaluated. 450,000 thyroid biopsies are performed annually. It is essential for cost containment to improve the process by which detected nodules are selected for biopsy Better guidelines are needed to determine which nodules can be observed without biopsy Guidelines are needed to decrease the number of biopsies performed on nodules detected incidentally at other imaging studies. Dissemination of guidelines regarding proper utilization of thyroid ultrasound to primary care providers is needed 15 Conclusions In this study of 200 consecutive patients referred for thyroid nodules 75 (37.5%) were found at Physical examination 7 cancers - 9% malignancy rate if found at PE 24 (12%) were found by patient 3 cancers 12.5% malignancy rate if found by patient 67 (33.5%) were found by other imaging (CT MRI Carotid US) 1 cancer - 1.5% malignancy rate if found by other imaging 34 were found when an US was performed for other reasons 1 cancer - 3% in a patient being evaluated for hyperparathyroidism No cancers found in the 18 cases where there was no accepted indication for the thyroid ultrasound. 16 Plans for additional investigation 1. Repeat the study in a similar thyroid referral practice in Sarasota, Florida 2. Repeat the study at a University-based Medical Center thyroid clinic. Assess whether the low rate of malignancy in incidentally found nodules is confirmed in other sites Assess whether the patterns of discovery are same with different geographic locations and referral patterns. Please scan for digital handout Or go to:
Incidence of Incidental Thyroid Nodules on Computed Tomography (CT) Scan of the Chest Performed for Reasons Other than Thyroid Disease
International Journal of Clinical Medicine, 2011, 2, 264-268 doi:10.4236/ijcm.2011.23042 Published Online July 2011 (http://www.scirp.org/journal/ijcm) Incidence of Incidental Thyroid Nodules on Computed
More informationGENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.
GENERAL CODING When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis. Exception: You must review and revise EOD coding for prostate
More informationThyroid Fine-Needle Aspiration Indications and Technique. Subcommittee members Zubair W. Baloch, MD, PhD Martha Bishop Pitman, MD
Thyroid Fine-Needle Aspiration Indications and Technique Subcommittee members Zubair W. Baloch, MD, PhD Martha Bishop Pitman, MD Thyroid FNA Indication Clinical Thyroid Nodule (s) > 1 cm? Hypo-functioning
More informationOBJECTIVES By the end of this segment, the community participant will be able to:
Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway
More informationNicole Kounalakis, MD
Breast Disease: Diagnosis and Management Nicole Kounalakis, MD Assistant Professor of Surgery Goal of Breast Evaluation The goal of breast evaluation is to classify findings as: normal physiologic variations
More informationDisease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200
GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung
More informationInfrared Thermography Not a Useful Breast Cancer Screening Tool
Contact: Jeanne-Marie Phillips Sharon Grutman HealthFlash Marketing The American Society of Breast Surgeons 203-977-3333 877-992-5470 Infrared Thermography Not a Useful Breast Cancer Screening Tool Mammography
More informationRecommendations for cross-sectional imaging in cancer management, Second edition
www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Breast cancer Faculty of Clinical Radiology www.rcr.ac.uk Contents Breast cancer 2 Clinical background 2 Who
More informationWriting Group for the AACE Thyroid Scientific Committee. Bernet V, Hupart KH, Parangi S and Woeber KA
Molecular Diagnostic Testing of Thyroid Nodules with Indeterminate Cytopathology Summary Highlights Writing Group for the AACE Thyroid Scientific Committee Bernet V, Hupart KH, Parangi S and Woeber KA
More informationSUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD
SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD Case Presentation 35 year old male referred from PMD with an asymptomatic palpable right neck mass PMH/PSH:
More informationBreast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.
Breast Cancer: from bedside and grossing room to diagnoses and beyond Adriana Corben, M.D. About breast anatomy Breasts are special organs that develop in women during puberty when female hormones are
More informationEvaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003
Evaluation and Management of the Breast Mass Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003 Common Presentations of Breast Disease Breast Mass Abnormal
More informationThyroid Cancer Diagnosis and Management. Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010
Thyroid Cancer Diagnosis and Management Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010 DISCLOSURE NOTHING TO DISCLOSE in regard to financial conflict
More informationThyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules)
Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules) Jeffrey S. Freeman, D.O., F.A.C.O.I. Chairman, Division of Endocrinology and Metabolism Philadelphia College
More informationD. FREQUENTLY ASKED QUESTIONS
ACR BI-RADS ATLAS D. FREQUENTLY ASKED QUESTIONS 1. Under MQSA, is it necessary to include a numeric assessment code (i.e., 0, 1, 2, 3, 4, 5, or 6) in addition to the assessment category in all mammography
More informationBreast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA
Breast Imaging Made Brief and Simple Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA What women are referred for breast imaging? Two groups of women are referred for
More informationConflict of Interest. Overdiagnosis. Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates 4/17/2015. Jeffrey F.
Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates Jeffrey F. Krane, MD PhD Associate Professor of Pathology Harvard Medical School Chief, Head and Neck Pathology Service Associate Director,
More informationBreast Ultrasound: Benign vs. Malignant Lesions
October 25-November 19, 2004 Breast Ultrasound: Benign vs. Malignant Lesions Jill Steinkeler,, Tufts University School of Medicine IV Breast Anatomy Case Presentation-Patient 1 62 year old woman with a
More informationLow-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital
Lung Cancer Screening with Low-dose CT Imaging Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital Despite recent declines in the incidence of lung cancer related to the
More informationCancer Screening. Robert L. Robinson, MD, MS. Ambulatory Conference SIU School of Medicine Department of Internal Medicine.
Cancer Screening Robert L. Robinson, MD, MS Ambulatory Conference SIU School of Medicine Department of Internal Medicine March 13, 2003 Why screen for cancer? Early diagnosis often has a favorable prognosis
More informationGuideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer
Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer Version History Version Date Summary of Change/Process 0.1 09.01.11
More informationMANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock Manchester 100 Hitchcock Way Manchester, NH 03104 (603) 695-2850
LEBANON Lung Cancer Screening Program One Medical Center Drive Lebanon, NH 03756 (603) 650-4400 (866) 966-1601 Toll-free cancer.dartmouth.edu/lungscreening MANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock
More informationTest Request Tip Sheet
With/Without Contrast CT, MRI Studies should NOT be ordered simultaneously as dual studies (i.e., with and without contrast). Radiation exposure is doubled and both views are rarely necessary. The study
More informationRotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
More informationUpdate on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery
Update on thyroid cancer surveillance and management of recurrent disease Minimally invasive thyroid surgery July 2006 Michael W. Yeh, MD Program Director, Endocrine Surgery Assistant Professor, David
More informationPatient sample criteria for the OPEIR Measures Group are all patients regardless of age, that have a specific CT procedure performed:
OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES GROUP OVERVIEW 2016 PQRS OPTIONS F MEASURES GROUPS: 2016 PQRS MEASURES IN OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES
More informationPET/CT in Lung Cancer
PET/CT in Lung Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria GLOBOCAN 2012 #1 #3 FDG-PET/CT
More informationOPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS FOR MEASURES GROUPS:
OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES
More informationIl percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare
Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare Maria Chiara Zatelli Sezione di Endocrinologia Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università
More informationHarlem Hospital Center Integrated Radiology Residency Program Mammography Educational goals and objectives
Harlem Hospital Center Integrated Radiology Residency Program Mammography Educational goals and objectives Rotation 1 (Radiology year 1/2) Knowledge Based Objectives: At the end of the rotation, the resident
More information2011 Radiology Diagnosis Coding Update Questions and Answers
2011 Radiology Diagnosis Coding Update Questions and Answers How can we subscribe to the Coding Clinic for ICD-9 guidelines and updates? The American Hospital Association publishes this quarterly newsletter.
More informationBreast Cancer Screening in Low- and Middle-Income Countries A Framework To Choose Screening Strategies
Breast Cancer Screening in Low- and Middle-Income Countries A Framework To Choose Screening Strategies Richard Wender, MD Session code: www.worldcancercongress.org A Five Step Framework to Guide Screening
More informationDisclosures. Definitions. CDC Website
Disclosures Deborah Grady, MD, MPH Professor of Medicine Deputy Editor, JAMA Internal Medicine Co-Director, Center for Healthcare Value Co-Director, Clinical and Translational Science Institute Salary
More informationUs TOO University Presents: Understanding Diagnostic Testing
Us TOO University Presents: Understanding Diagnostic Testing for Prostate Cancer Patients Today s speaker is Manish Bhandari, MD Program moderator is Pam Barrett, Us TOO International Made possible by
More informationSeton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization 2007 2012 N = 50
General Data Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization 2007 2012 N = 50 The vast majority of the patients in this study were diagnosed
More informationMEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15
MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases,
More informationScreening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group
Screening for Cancer in Light of New Guidelines and Controversies Christopher Celio, MD St. Jude Heritage Medical Group Screening Tests The 2 major objectives of a good screening program are: (1) detection
More informationNon-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines
Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines April 2008 (presented at 6/12/08 cancer committee meeting) By Shelly Smits, RHIT, CCS, CTR Conclusions by Dr. Ian Thompson, MD Dr. James
More informationIII. REPORTING SYSTEM
ACR BI-RADS ATLAS BREAST III. REPORTING SYSTEM American College of Radiology 121 2013 122 American College of Radiology ACR BI-RADS ATLAS BREAST A. REPORT ORGANIZATION The report should be concise and
More informationExamples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening.
CANCER SCREENING Dr. Tracy Sexton (updated July 2010) What is screening? Screening is the identification of asymptomatic disease or risk factors by history taking, physical examination, laboratory tests
More informationTHYROID CANCER. I. Introduction
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
More informationValidation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach
Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach Kerry C. Councilman, MD Assistant Professor University of Colorado Denver Goals: BRAF Mutation
More informationIntroduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.
Male Breast Cancer Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too. Many people do not know that men can get breast
More informationSustaining a High-Quality Breast MRI Practice
Sustaining a High-Quality Breast MRI Practice Christoph Lee, MD, MSHS Associate Professor of Radiology Adjunct Associate Professor, Health Services University of Washington September 11, 2015 Overview
More informationloving life YOUR GUIDE TO YOUR THYROID
loving life YOUR GUIDE TO YOUR THYROID one THE THYROID two HYPOTHYROIDISM three HYPERTHYROIDISM four TREATING HYPERTHYROIDISM five THYROID NODULES AND GOITRES one THE THYROID What is the thyroid? The thyroid
More informationMesothelioma. 1995-2013, The Patient Education Institute, Inc. www.x-plain.com ocft0101 Last reviewed: 03/21/2013 1
Mesothelioma Introduction Mesothelioma is a type of cancer. It starts in the tissue that lines your lungs, stomach, heart, and other organs. This tissue is called mesothelium. Most people who get this
More informationThe Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.
Where does Molecular Analysis of FNA Specimens fit into the evaluation of thyroid nodules? The Role of Genetic Testing in the Evaluation of Thyroid Nodules Ultrasound TSH Risk factors Jill E. Langer, MD
More informationFirst floor, Main Hospital North Services provided 24/7 365 days per year
First floor, Main Hospital North Services provided 24/7 365 days per year General Radiology (X-ray) Fluoroscopy Ultrasound (Sonography) Nuclear Medicine P.E.T. imaging Computed Tomography (CT scan) Magnetic
More informationLung Cancer Screening
Lung Cancer Screening Middlesex Hospital Total Lung Care Center Megin Iaccarino RN, BSN Lung Pathway Coordinator and Lung Nurse Navigator Middlesex Hospital Cancer Center and Surgical Alliance Lung Screening
More informationEverything You Ever Wanted to Know About the Thyroid
Everything You Ever Wanted to Know About the Thyroid (but were afraid to ask ) Caroline Messer, MD Board Certified Internist, Endocrinologist, and Physician Nutrition Specialist Topics Thyroid Nodules
More informationFRIEND TO FRIEND CPT CODES 2015 2016. Diagnostic digital breast tomosynthesis, unilateral (list separately in addition to code for primary procedure)
FRIEND TO FRIEND CPT CODES 2015 2016 CPT CODE SERVICE DESCRIPTION FEE EFFECTIVE G0101 Screening pelvic examination $36.69 01 Jan 16 G0202 Mammography, screening, digital, bilateral (2 view film study of
More informationLung Cancer: Diagnosis, Staging and Treatment
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer begins in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.
More informationAnalysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data
The 2014 Cancer Program Annual Public Reporting of Outcomes/Annual Site Analysis Statistical Data from 2013 More than 70 percent of all newly diagnosed cancer patients are treated in the more than 1,500
More informationMammography. What is Mammography?
Scan for mobile link. Mammography Mammography is a specific type of breast imaging that uses low-dose x-rays to detect cancer early before women experience symptoms when it is most treatable. Tell your
More informationLOYOLA UNIVERSITY MEDICAL CENTER RESIDENCY PROGRAM IN GENERAL SURGERY CLINICAL ROTATION DESCRIPTION
LOYOLA UNIVERSITY MEDICAL CENTER RESIDENCY PROGRAM IN GENERAL SURGERY CLINICAL ROTATION DESCRIPTION Loyola University Medical Center Department of Surgery Endocrine Surgery RESIDENT COMPLEMENT: ROTATION
More informationTHORACIC DIAGNOSTIC ASSESMENT PROGRAM (DAP) PATIENT INFORMATION FOR:
central east regional cancer program in partnership with cancer care ontario THORACIC DIAGNOSTIC ASSESMENT PROGRAM (DAP) PATIENT INFORMATION FOR: Thoracic dap booklet March2012.indd 1 SCHEDULED TESTS YOUR
More informationGoiter. This reference summary explains goiters. It covers symptoms and causes of the condition, as well as treatment options.
Goiter Introduction The thyroid gland is located at the base of your neck. If the gland becomes abnormally enlarged, it is called a goiter. Goiters usually do not cause pain. But a large goiter could cause
More informationDanish Lung Cancer Screening Trial (DLCST).
Danish Lung Cancer Screening Trial (DLCST). Röntgenveckan, Karlstad 11.september 2014 Jesper Holst Pedersen, MD, DMsci, Associate Professor Rigshospitalet University of Copenhagen, Denmark DLCST (Danish
More informationPost-PET Restaging Cancer Form National Oncologic PET Registry
Post-PET Restaging Cancer Form National Oncologic PET Registry Facility ID #: Registry Case Number: Patient Name: Your patient had a PET scan on: mm/dd/yyyy. The PET scan was done for restaging of (cancer
More informationThyroid Cancer: Resection, Dissection, Surveillance and Recurrence. Cord Sturgeon, MD
Thyroid Cancer: Resection, Dissection, Surveillance and Recurrence Cord Sturgeon, MD Associate Professor of Surgery Northwestern University Feinberg School of Medicine Director of Endocrine Surgery Chicago,
More informationSonographic Features of Medullary Thyroid Carcinomas According to Tumor Size
ORIGINAL RESEARCH Sonographic Features of Medullary Thyroid Carcinomas According to Tumor Size Comparison With Papillary Thyroid Carcinomas Liguang Zhou, MD, Bo Chen, MD, Miaoqing Zhao, MD, Huawei Zhang,
More informationwww.downstatesurgery.org
Male Breast Cancer Rabih Nemr MD Kings County Hospital August 2008 ACGME Core Competencies 1 Patient t Care Medical Knowledge 2 g 3 4 Practice Based Learning/Improvement Interpersonal Communication Skills
More informationSurgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科
Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科 Papillary microcarcinoma of thyroid Definition latent aberrant thyroid occult thyroid carcinoma latent papillary carcinoma)
More informationThymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available.
Thymus Cancer Introduction Thymus cancer is a rare cancer. It starts in the small organ that lies in the upper chest under the breastbone. The thymus makes white blood cells that protect the body against
More informationPRACTICAL TIPS IN ENSURING RADIATION SAFETY IN THE USE OF MEDICAL DIAGNOSTIC X-RAY EQUIPMENT
PRACTICAL TIPS IN ENSURING RADIATION SAFETY IN THE USE OF MEDICAL DIAGNOSTIC X-RAY EQUIPMENT Although the medical uses of X-rays to examine a patient without surgery became an amazing medical breakthrough,
More informationLung cancer forms in tissues of the lung, usually in the cells lining air passages.
Scan for mobile link. Lung Cancer Lung cancer usually forms in the tissue cells lining the air passages within the lungs. The two main types are small-cell lung cancer (usually found in cigarette smokers)
More informationNICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.
More informationLocoregional recurrence or persistence of papillary carcinoma: radioiodine treatment
Locoregional recurrence or persistence of papillary carcinoma: radioiodine treatment Michele Klain, Marco Salvatore Department of Functional and Biomorphological Science University of Naples "Federico
More informationDocumentation Guidelines for Physicians Interventional Pain Services
Documentation Guidelines for Physicians Interventional Pain Services Pamela Gibson, CPC Assistant Director, VMG Coding Anesthesia and Surgical Divisions 343.8791 1 General Principles of Medical Record
More informationThere must be an appropriate administrative structure for each residency program.
Specific Standards of Accreditation for Residency Programs in Radiation Oncology 2015 VERSION 3.0 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation
More informationBRAF in the diagnostic evaluation of thyroid nodules
Symposium 13 Molecular markers in thyroid cancer: current role in clinical practice BRAF in the diagnostic evaluation of thyroid nodules Laura Fugazzola University of Milan, Italy Papillary carcinoma BRAF
More informationSonographic Findings in the Surgical Bed After Thyroidectomy
Article Sonographic Findings in the Surgical Bed After Thyroidectomy Comparison of Recurrent Tumors and Nonrecurrent Lesions Jung Hee Shin, MD, Boo-Kyung Han, MD, Eun Young Ko, MD, Seok Seon Kang, MD Objective.
More informationMolecular Markers in Fine Needle Aspirates of the Thyroid
Molecular Markers in Fine Needle Aspirates of the Thyroid Policy Number: 2.04.78 Last Review: 3/2015 Origination: 3/2013 Next Review: 3/2016 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will
More informationMeasure Title X RAY PRIOR TO MRI OR CAT SCAN IN THE EVAULATION OF LOWER BACK PAIN Disease State Back pain Indicator Classification Utilization
Client HMSA: PQSR 2009 Measure Title X RAY PRIOR TO MRI OR CAT SCAN IN THE EVAULATION OF LOWER BACK PAIN Disease State Back pain Indicator Classification Utilization Strength of Recommendation Organizations
More informationHow To Know If You Have Cancer At Mercy Regional Medical Center
MERCY REGIONAL CANCER CENTER 2012 CANCER PROGRAM ANNUAL REPORT Using 2011 Data Mercy Regional Cancer Center When you have cancer, you might think first of treatments chemotherapy and radiation. You want
More informationTable of Contents. User Instructions...Page 2. Group Administrator (Chief/Department Chair or Point of Contact (POC).Page 3
Table of Contents User Instructions......Page 2 Group Administrator (Chief/Department Chair or Point of Contact (POC).Page 3 Report Index and Sample Reports.Page 16 Example of Scoring..Page 19 1 RADPEER
More informationChapter 2 Coding, Billing, and Reimbursement for Procedures
Chapter 2 Coding, Billing, and Reimbursement for Procedures Cathryn B. Heath Introduction Coding, billing, and reimbursement are an integral part of the procedures performed in today s modern medical office.
More informationKidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
More informationHodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla
Hodgkin Lymphoma Disease Specific Biology and Treatment Options John Kuruvilla My Disclaimer This is where I work Objectives Pathobiology what makes HL different Diagnosis Staging Treatment Philosophy
More informationModifiers 25 and 59. Modifier 25
Modifiers 25 and 59 This article discusses the appropriate use of modifier 25, Significant, Separately Identifiable Evaluation and Management Service by the Same Physician on the Same Day of the Procedure
More informationAACE Advances in Medical and Surgical Management of Thyroid Cancer, 2015. Tampa, Florida.
AACE Advances in Medical and Surgical Management of Thyroid Cancer, 2015. Tampa, Florida. Dev Abraham MD, MRCP (UK), ECNU Professor of Medicine, Division of Endocrinology, Huntsman Cancer Institute, University
More informationPre test Question 2. Emily D. Babcock, DHSc, PA C, DFAAPA CAPA Annual Conference Palm Springs, California October 4, 2013
Emily D. Babcock, DHSc, PA C, DFAAPA CAPA Annual Conference Palm Springs, California October 4, 2013 Objectives After completion of this presentation, the participant will be able to: Explain the current
More information.org. Osteochondroma. Solitary Osteochondroma
Osteochondroma Page ( 1 ) An osteochondroma is a benign (noncancerous) tumor that develops during childhood or adolescence. It is an abnormal growth that forms on the surface of a bone near the growth
More informationMedicare Part B. Mammograms - Updated Billing Guide for Screening and Diagnostic Tests
Mammograms - Updated Billing Guide for Screening and Diagnostic Tests This article from Medicare B News Issue 223 dated October 21, 2005 is being updated and reprinted to ensure that the Noridian Administrative
More informationCrosswalk for Positron Emission Tomography (PET) Imaging Codes G0230 G0030, G0032, G0034, G0036, G0038, G0040, G0042, G0044, G0046
Positron Emission Tomography (PET) CPT to HCPCS Level Crosswalk Changes below from CMS Change Request 3741 Transmittals 518 & 31 published on April 1, 2005; mplementation of CPT codes are effective January
More informationCorporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid
Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_markers_in_fine_needle_aspirates_of_the_thyroid
More informationAdvances in Differentiated Thyroid Cancer
Advances in Differentiated Thyroid Cancer Steven A. De Jong, M.D., FACS, FACE Professor and Vice Chair Clinical Affairs Department of Surgery Loyola University Medical Center Thyroid Cancer classification
More informationPhyllodes tumours: borderline malignant and malignant
Phyllodes tumours: borderline malignant and malignant This booklet is for people who would like more information on borderline malignant or malignant phyllodes tumours. It describes what they are, the
More informationMeasure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care
Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION:
More informationDiagnosis and Prognosis of Pancreatic Cancer
Main Page Risk Factors Reducing Your Risk Screening Symptoms Diagnosis Treatment Overview Chemotherapy Radiation Therapy Surgical Procedures Lifestyle Changes Managing Side Effects Talking to Your Doctor
More informationBreast Density Legislation: Implications for primary care providers
Breast Density Legislation: Implications for primary care providers Deborah J. Rhodes MD Associate Professor of Medicine 2012 MFMER slide-1 Disclosure Relevant financial relationship(s) None Off-label
More informationBreast Cancer Follow-Up
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Breast Cancer Follow-Up Breast Cancer Follow-Up Version 2002: Thomssen / Scharl Version 2003 2009: Bauerfeind / Bischoff /
More informationMetastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy
Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy Sarah Hutto,, MSIV Marc Underhill, M.D. January 27, 2009 Past History 45 yo female
More informationBreast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis?
Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis? Erin I. Lewis, BUSM 2010 Cheri Nguyen, BUSM 2008 Priscilla Slanetz, M.D., MPH Al Ozonoff, Ph.d.
More informationBreast. Patient information. cancer clinical pathway
Breast Patient information cancer clinical pathway This leaflet was written to properly inform people following breast cancer treatment plan. It doesn t replace the dialogue with healthcare staff; it rather
More informationMalpractice and the Infectious Disease Any Physician WHAT YOU SHOULD KNOW! Why this talk? Why me?
Malpractice and the Infectious Disease Any Physician WHAT YOU SHOULD KNOW! G.R. Donowitz 2015 Why this talk? Why me? Expert witness for a long time Defense and Plaintiff work Have said, No, no case and
More informationIncidental Radiology Findings: Effectiveness of a Radiology Electronic Medical Records Interface System for Improving Communication
Incidental Radiology Findings: Effectiveness of a Radiology Electronic Medical Records Interface System for Improving Communication Charles L. Emerman, MD, Mary A. Gallagher, and Pedro J. Diaz, PhD Abstract
More informationThere are many different types of cancer and sometimes cancer is diagnosed when in fact you are not suffering from the disease at all.
About Cancer Cancer is a disease where there is a disturbance in the normal pattern of cell replacement. The cells mutate and become abnormal or grow uncontrollably. Not all tumours are cancerous (i.e.
More information